U
Umoja is developing a new approach to cancer therapy that retools a patient’s immune system in vivo, enhancing the body’s natural capacity to fight cancer. We envision a world where all patients have access to the most advanced immunotherapies and are free from the burdens of traditional cancer therapies.
Investor insights
Funding rounds participated in
$100M sweet spot round size
Investor type
Privately Held
Basic info
Industry
Biotechnology Research
Sectors
Biotechnology Research
Date founded
2019
Funding rounds raised
Total raised
$100M
from 3 investors over 1 rounds
U
Umoja Biopharma raised $100M on February 14, 2025
Investors: Double Point Ventures, DCVC Bio and + 12 Other investors